Concenter BioPharma develops drugs for treating and preventing type 2 diabetes. The company has developed a family of nonsteroidal chemical complexes made from components approved for clinical use. These new chemical entities constitute a protected platform of drugs with proven efficacy and safety.
The members of the platform act as potent anti-inflammatory agents, strong iron-chelating agents, and antibiotic agents. These modes of action jointly assist in treating the causes and/or symptoms of multiple indications.
Concenter BioPharma is a subsidiary of Silkim Pharma.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Concenter BioPharma Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Aug 26, 2020
www.geektime.co.il
סטארטאפ ישראלי מפתח תרופה לסוכרת סוג 2
#Investment
Jan 13, 2020
www.israel21c.org
Finally, a pill that could fix the root cause of diabetes